secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2026-09-01T10:00:27+00:00
Accession:  0001193125-26-377362
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines signs 4-building lease for new Redwood City HQ (672k sq ft, ~$2.7M/mo)
--------------------------------------------------------------------------------

- Leases for four Seaport Blvd buildings (1600-1900) totaling ~672,000 rentable sq ft as new HQ; effective subject to Phase II Closing.
- Commencement staggered Sep 26, 2027–Sep 1, 2028; initial terms end Sep 2042 with three 5-yr extension options.
- Aggregate base rent starts ~$2.7M/month at full commencement, +3% annually; rent abatement ~$23.1M through Jan 2030.
- Tenant improvement allowances ~$115.9M plus optional additional ~$40.3M (amortized at 10% annually as extra rent).
- Related-party: Farallon (owns ~6.4% of RVMD) indirectly owns majority of landlords; Leases create direct financial obligation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/0001193125-26-377362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/rvmd-20260827.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-377362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer